Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Starting soon

Conditions studied: Generalized Anxiety Disorder

In brief

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial. Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Key facts

Study ID

NCT06254157

Run by

Power Life Sciences Inc.

People needed

500

Starts

2025-03-01

Expected to finish

2027-03-01

Last updated by the study team

2024-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of generalized anxiety disorder
• Participant must be 18 years of age or older
• Participant must be willing and able to comply with scheduled visits, treatment schedule, laboratory tests, and other requirements of the study.

You may not qualify if…

• Pregnant or lactating woman
• Participant is actively receiving study therapy in another
• Inability to provide written informed consent

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.